Cargando…

Blanking period antiarrhythmic drugs after catheter ablation for atrial fibrillation: a meta-analysis of randomized controlled trials

BACKGROUND: Antiarrhythmic drugs (AADs) are frequently prescribed following catheter ablation (CA) for atrial fibrillation (AF). However, to date, there is a lack of large-scale, multicenter controlled studies that have confirmed the efficacy of AADs in reducing the incidence of late recurrence of A...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Gang, Li, Guangling, Zhang, Demei, Wang, Xiaomei, Guo, Xueya
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Cardiovascular Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10397410/ https://www.ncbi.nlm.nih.gov/pubmed/37547248 http://dx.doi.org/10.3389/fcvm.2023.1071950

Ejemplares similares

Predicting Late Recurrence of Atrial Fibrillation After Radiofrequency Ablation in Patients With Atrial Fibrillation: Comparison of C2HEST and HATCH Scores
por: Han, Jingjing, et al.
Publicado: (2022)

Development and validation of a novel risk model for predicting atrial fibrillation recurrence risk among paroxysmal atrial fibrillation patients after the first catheter ablation
por: Li, Guangling, et al.
Publicado: (2022)

Research Progress of Myocardial Fibrosis and Atrial Fibrillation
por: Li, Guangling, et al.
Publicado: (2022)

Association between specific antiarrhythmic drug prescription in the post-procedural blanking period and recurrent atrial arrhythmias after catheter ablation for atrial fibrillation
por: Malladi, Chaitanya L., et al.
Publicado: (2021)

Comparison of health-related quality of life in patients with atrial fibrillation treated with catheter ablation or antiarrhythmic drug therapy: a systematic review and meta-analysis protocol
por: Allan, Katherine S, et al.
Publicado: (2017)

Ablation and antiarrhythmic drug effects on PITX2(+/−) deficient atrial fibrillation: A computational modeling study
por: Jin, Ze, et al.
Publicado: (2022)

Evaluation of redo procedures in blanking period following atrial fibrillation catheter ablation
por: Coteli, C, et al.
Publicado: (2023)

Cost-effectiveness of Catheter Ablation Versus Antiarrhythmic Drug Therapy for the Treatment of Atrial Fibrillation: A Canadian Perspective
por: Khaykin, Yaariv, et al.
Publicado: (2016)

Catheter ablation versus antiarrhythmic drugs with risk factor modification for treatment of atrial fibrillation: a protocol of a randomised controlled trial (PRAGUE-25 trial)
por: Osmancik, Pavel, et al.
Publicado: (2022)

The atrial fibrillation burden during the blanking period is predictive of time to recurrence after catheter ablation
por: Silva Cunha, Pedro, et al.
Publicado: (2022)

Cost-effectiveness of rhythm control strategy: Ablation versus antiarrhythmic drugs for treating atrial fibrillation in Korea based on real-world data
por: Kim, Woojin, et al.
Publicado: (2023)

Sex difference in atrial fibrillation recurrence after catheter ablation and antiarrhythmic drugs
por: Park, Yoon Jung, et al.
Publicado: (2023)

Assessment of High-Power Catheter Ablation in Patients With Atrial Fibrillation: A Meta-Analysis
por: Mao, Zhi-Jie, et al.
Publicado: (2021)

Zero fluoroscopy catheter ablation for atrial fibrillation: a systematic review and meta-analysis
por: Debreceni, Dorottya, et al.
Publicado: (2023)

Editorial: Atrial fibrillation: insights on mechanisms, mapping and catheter ablation
por: Conti, Sergio, et al.
Publicado: (2023)

Catheter ablation and thoracoscopic ablation in long persistent atrial fibrillation with large left atrium
por: Park, Chan Soon, et al.
Publicado: (2022)

Antiarrhythmic drug therapy after catheter ablation for atrial fibrillation—Insights from the German Ablation Registry
por: Schleberger, Ruben, et al.
Publicado: (2021)

Outcomes of catheter ablation vs. medical treatment for atrial fibrillation and heart failure: a meta-analysis
por: Lee, Wei-Chieh, et al.
Publicado: (2023)

Early recurrence during the blanking period and left atrial reverse remodeling after catheter ablation for non-paroxysmal atrial fibrillation
por: Oka, Takafumi, et al.
Publicado: (2020)

Atrial fibrillation ablation with a spring sensor-irrigated contact force-sensing catheter compared with other ablation catheters: systematic literature review and meta-analysis
por: Macle, Laurent, et al.
Publicado: (2019)

Sex-Related Differences in Catheter Ablation for Patients With Atrial Fibrillation and Heart Failure
por: Chibber, Tamanna, et al.
Publicado: (2020)

Malnutrition and Risk of Procedural Complications in Patients With Atrial Fibrillation Undergoing Catheter Ablation
por: Kim, Daehoon, et al.
Publicado: (2021)

Machine Learning-Predicted Progression to Permanent Atrial Fibrillation After Catheter Ablation
por: Park, Je-Wook, et al.
Publicado: (2022)

Plasma myeloperoxidase: association with atrial fibrillation progression and recurrence after catheter ablation
por: Liu, Jingmeng, et al.
Publicado: (2023)

Efficacy of left atrial low-voltage area-guided catheter ablation of atrial fibrillation: An updated systematic review and meta-analysis
por: Zhou, Yaqiong, et al.
Publicado: (2022)

Catheter ablation vs. drug therapy in the treatment of atrial fibrillation patients with heart failure: An update meta-analysis for randomized controlled trials
por: Lin, Chun, et al.
Publicado: (2023)

Effect of Left Atrial Appendage Closure in Combination With Catheter Ablation on Left Atrial Function for Persistent Atrial Fibrillation
por: Yang, Jing, et al.
Publicado: (2021)

Heart failure risk in patients with atrial fibrillation treated with catheter ablation vs antiarrhythmic drugs
por: Gruber, Megan, et al.
Publicado: (2023)

Cryoballoon catheter ablation or drug therapy to delay progression of atrial fibrillation: A single-center randomized trial
por: Ding, Jun, et al.
Publicado: (2022)

Indexed Left Atrial Adipose Tissue Area Is Associated With Severity of Atrial Fibrillation and Atrial Fibrillation Recurrence Among Patients Undergoing Catheter Ablation
por: Sanghai, Saket R., et al.
Publicado: (2018)

Left atrial appendage flow velocity predicts recurrence of atrial fibrillation after catheter ablation: A systematic review and meta-analysis
por: Chen, Pengfei, et al.
Publicado: (2022)

Left atrial appendage function and structure predictors of recurrent atrial fibrillation after catheter ablation: A meta-analysis of observational studies
por: Han, Shaojie, et al.
Publicado: (2022)

Efficacy and Safety of High-Power Short-Duration Radiofrequency Catheter Ablation of Atrial Fibrillation
por: Park, Je-Wook, et al.
Publicado: (2021)

Uninterrupted DOACs Approach for Catheter Ablation of Atrial Fibrillation: Do DOACs Levels Matter?
por: Hardy, Michael, et al.
Publicado: (2022)

Extra-Pulmonary Vein Triggers at de novo and the Repeat Atrial Fibrillation Catheter Ablation
por: Kim, Daehoon, et al.
Publicado: (2021)

The Association Between Subclinical Thyroid Dysfunction and Recurrence of Atrial Fibrillation After Catheter Ablation
por: Li, Rui-bin, et al.
Publicado: (2022)

Case report: Catheter ablation for persistent atrial fibrillation in a patient with heart of stone
por: Deng, Yingjian, et al.
Publicado: (2023)

Impact of pulmonary artery pressure on recurrence after catheter ablation in patients with atrial fibrillation
por: Choi, Yun Young, et al.
Publicado: (2023)

Periodontitis was associated with worse clinical outcomes after catheter ablation for paroxysmal atrial fibrillation
por: Tashiro, Akira, et al.
Publicado: (2023)

Gender, ethnic, and socioeconomic differences in access to catheter ablation therapy in patients with atrial fibrillation
por: Hamade, Hani, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_c97bme65t3v02cff3g2grgjne0